United Kingdom

Destiny Pharma plc

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sir Nigel Rudd
Chairman
1 purchase — total 31,000 GBP
Buy 2 Aug 2024
Value £3,564,315.88 | Price 119.12 | Shares 69,424
Buy 9 Oct 2023
Value £250,353.52 | Price 458.50 | Shares 30,253
Buy 26 May 2023
Value £6,037.96 | Price 0.30 | Shares 20,000
Buy 25 May 2023
Value £15,500.00 | Price 0.31 | Shares 50,000
Buy 25 May 2023
Value £6,600.00 | Price 0.33 | Shares 20,000
Buy 25 May 2023
Value £15,337.87 | Price 0.31 | Shares 49,477
Buy 25 May 2023
Value £4,485.73 | Price 0.30 | Shares 14,780
Buy 27 Feb 2023
Value £6,788.00 | Price 0.34 | Shares 20,000
Buy 27 Sep 2021
Value £2,515.80 | Price 1.20 | Shares 2,100
Sale 10 Jun 2021
Value £420,000.00 | Price 1.20 | Shares 350,000
Buy 29 Apr 2021
Value £2,246.86 | Price 1.49 | Shares 1,511
Buy 22 Apr 2021
Value £7,900.00 | Price 1.58 | Shares 5,000
Buy 6 Jan 2021
Value £7,920.00 | Price 0.88 | Shares 9,000
Buy 4 Jun 2018
Value £39,394.32 | Price 1.10 | Shares 35,800
Through Lady Lesley Rudd, a closely affiliated person
Buy 4 Jun 2018
Value £43,025.64 | Price 1.10 | Shares 39,100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02 B Purchase
Sir Nigel Rudd

Chairman

Director
69,424
119.12
£3,564,316 		69,424 119.12 £3,564,316
2023-10-10 2023-10-09 B Purchase
Chris Tovey

Chief Executive Officer

Officer
30,253
458.50
£250,354 		30,253 458.50 £250,354
2023-05-26 2023-05-26 B Purchase
3.3
Nick Rodgers

Chairman

Director
94,225
35.11
£2,883,899 		94,225 35.11 £2,883,899
2023-05-26 2023-05-25 B Purchase
Aled Williams

Non-Executive Director

Executive Director
50,000
0.31
£15,500 		50,000 0.31 £15,500
2023-05-26 2023-05-25 B Purchase
0.6
Debra Barker

Interim Chief Executive Officer

Officer
20,000
0.33
£6,600 		20,000 0.33 £6,600
2023-05-26 2023-05-25 B Purchase
3.3
Nick Rodgers

Chairman

Director
49,477
0.31
£15,338 		49,477 0.31 £15,338
2023-05-26 2023-05-25 B Purchase
3.3
Nick Rodgers

Chairman

Director
14,780
0.30
£4,486 		14,780 0.30 £4,486
2023-02-27 2023-02-27 B Purchase
3.3
Nick Rodgers

Chairman

Director
20,000
0.34
£6,788 		20,000 0.34 £6,788
2021-09-27 2021-09-27 B Purchase
3.3
Nick Rodgers

Chairman

Director
2,100
1.20
£2,516 		2,100 1.20 £2,516
2021-06-10 2021-06-10 S Sale
Dr William Love

Chief Scientific Officer

Officer
350,000
1.20
£420,000 		350,000 1.20 £420,000
2021-04-30 2021-04-29 B Purchase
3.3
Nick Rodgers

Chairman

Director
1,511
1.49
£2,247 		1,511 1.49 £2,247
2021-04-23 2021-04-22 B Purchase
3.3
Nick Rodgers

Chairman

Director
5,000
1.58
£7,900 		5,000 1.58 £7,900
2021-01-07 2021-01-06 B Purchase
3.3
Nick Rodgers

Chairman

Director
9,000
0.88
£7,920 		9,000 0.88 £7,920
2018-06-05 2018-06-04 B Purchase
Sir Nigel Rudd

Non-Executive Chairman

Through Lady Lesley Rudd, a closely affiliated person Director
35,800
1.10
£39,394 		35,800 1.10 £39,394
2018-06-05 2018-06-04 B Purchase
Sir Nigel Rudd

Non-Executive Chairman

Director
39,100
1.10
£43,026 		39,100 1.10 £43,026
Explore more

More insider trading research around Destiny Pharma plc

More insider trades in United Kingdom
Insider trading in Europe